The SYNLAB Nigeria approach to global standards and improved patient outcomes.advertisement In Nigeria’s healthcare system, ...

Quest Diagnostics (DGX) delivered earnings and revenue surprises of +5.45% and +3.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Quest Diagnostics expects full-year earnings in the range of $10.63 to $10.83 per share, with revenue in the range of $11.78 billion to $11.9 billion. This story was generated by Automated Insights ( ...

Advanced diagnostics in brain health, specifically the AD-Detect Alzheimer's portfolio, saw revenue more than double ...

STD Diagnostics Market OutlookThe global STD diagnostics market is projected to grow at a CAGR of 7–8% during the forecast period, driven by the rising burden of sexually transmitted diseases ...

Quest Diagnostics on Tuesday raised its forecast for 2026 profit and revenue after posting first-quarter results above Wall Street estimates, citing resilient demand for routine ​diagnostic testing.

Buy the dip on Abbott (ABT): diversified healthcare growth, Exact Sciences boost, strong dividend, and discounted ...

The company claims the tool can compress a task that typically takes around 30 minutes into a few minutes, based on early ...

This study demonstrates that common two-tiered Lyme tests, utilized for decades, often fail to detect early Lyme disease and ...

Partnership Highlights bioLytical Laboratories Inc. is partnering with the Together TakeMeHome program to support expanded access to HIV ...

First quarter revenues of $2.90 billion, up 9.2% from 2025, with 9.0% organic revenue growth First quarter reported diluted earnings per share ("EPS") of $2.24, ...

Vermont Business Magazine Copley Hospital is proud to announce that its laboratory has once again earned accreditation from the College of American Pathologists (CAP). This globally recognized gold ...